Phase 2 Shigella Vaccine and Challenge

NCT04242264 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

NIH

Sponsor class

Conditions

Immunisation
Shigella Infection

Interventions

OTHER: Placebo
BIOLOGICAL: Shigella sonnei strain 53G
BIOLOGICAL: WRSs2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)